Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antimicrobial alginate fiber, and preparation method for and use of dressing thereof

Active Publication Date: 2019-09-19
HUIZHOU HUAYANG MEDICAL EQUIP
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent discusses another type of alginate dressing that has improved antimicrobial properties. This is achieved by combining the alginate with a compound called polyhexamethylene biguanide hydrochloride, which is a safe and effective antimicrobial agent. The dressing has good wound care properties such as safety, non-toxicity, high hygroscopicity, hemostasis, gelation, and promoting wound healing. The patent also introduces a new generation of antimicrobial dressings that use polyhexamethylene biguanide hydrochloride as an antimicrobial agent. Overall, this patent provides a solution for combining the characteristics of alginate and polyhexamethylene biguanide hydrochloride in a wound dressing.

Problems solved by technology

However, the alginate dressing lacks antimicrobial properties.
However, the polyhexamethylene biguanide salt has potential carcinogenicity, mutagenicity and reproductive toxicity at higher levels.
However, the chitosan itself is not a broad spectrum antimicrobial agent, and the antimicrobial activity can barely meet the expected requirement.
The medicine causes drug resistance and has other potential adverse side effects.
The antimicrobial alginate compound dressing has good anti-infectious effect, but a high level of honey is required, which increases manufacture cost.
A silver-containing alginate dressing is widely used in clinical practice, but when an organism absorbs silver, it causes toxicity and occurrence of drug-resistant microorganisms.
An in vitro cellular study discovered that, the silver-containing alginate dressing affects cell morphology of keratinocytes and fibroblasts, reduces fibroblast regeneration, and inhibits collagen synthesis in fibroblasts, so that the silver-containing alginate dressing hinders wound healing and produces sustained cytotoxicity.
Silver can enter body's cells to induce a potential risk of neurodegenerative diseases.
However, published literature show that nano-silver has some cytotoxicity.
The macromolecular polyguanidine is almost instantly dissolved in water, which is potentially highly risky.
An antimicrobial evaluation model in the patent is problematic.
In addition, the polyhexamethylene biguanide hydrochloride loaded on the alginate is highly soluble in water by the conventional soaking method, and the technique requires a high level of polyhexamethylene biguanide hydrochloride (0.5%-10%) to be added, which is highly risky.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antimicrobial alginate fiber, and preparation method for and use of dressing thereof
  • Antimicrobial alginate fiber, and preparation method for and use of dressing thereof
  • Antimicrobial alginate fiber, and preparation method for and use of dressing thereof

Examples

Experimental program
Comparison scheme
Effect test

embodiment 1

[0060]A method is provided for manufacturing an antimicrobial alginate fiber dressing. A short alginate fiber with length of 3 to 5 cm is provided with 1000 g, and is placed into 5000 g of aqueous solution containing 0.54% of hydrochloric acid and 9.5% of ethanol, at 20° C. The solution with the alginate fiber is stirred and activated for 3.0 hours, and then the alginate fiber is separated from the aqueous solution by centrifuge. The alginate fiber may be soaked with 2000 g of absolute ethanol for 10 to 15 minutes, and then ethanol is separated by centrifuge to obtain a primary activated alginate fiber. 110 g of N,N-diisopropylethylamine is added into 5500 g of chloroform solution (triphenylphosphine: 0.235%, and iodine: 0.228%) with stirring at 70 r / min, and the stirring time is counted by a timer. After stirring for 1-2 minutes, the primary activated alginate fiber is put into the chloroform solution. The chloroform solution may be stirred for 3 to 5 minutes, and then is activated...

embodiment 2

[0062]A method is for manufacturing an antimicrobial alginate fiber dressing. A short alginate fiber with length of 3 to 5 cm may be provided with 1000 g, and is placed into 5000 g of aqueous solution containing 0.54% of hydrochloric acid and 9.5% of ethanol, at 20° C. The alginate fiber in the aqueous solution is stirred and activated for 3.0 hours, and then the alginate fiber is separated from the aqueous solution by centrifuge. The fiber alginates may be then soaked with 2000 g of absolute ethanol for 10 to 15 minutes, and the ethanol is separated by centrifuge to obtain a primary activated alginate fiber. 110 g of N,N-diisopropylethylamine is added into 5500 g of chloroform solution (triphenylphosphine: 0.235%, and iodine: 0.228%) with stirring at 70 r / min, and the stirring time is counted by a timer. After stirring for 1-2 minutes, the primary activated alginate fiber is placed into the chloroform solution. The alginate fiber in the chloroform solution is stirred for 3 to 5 min...

embodiment 3

[0064]A method is for manufacturing an antimicrobial alginate fiber dressing. A long alginate fiber is provided with 1000 g, and is placed into 5000 g of aqueous solution containing 0.54% of hydrochloric acid and 9.5% of ethanol, at 20° C. The alginate fiber in the aqueous solution is stirred and activated for 3.0 hours, and then the alginate fiber is separated from the aqueous solution by centrifuge to remove liquid. The alginate fiber may be soaked with 2000 g of absolute ethanol for 10 to 15 minutes, and then ethanol is separated by centrifuge to obtain a primary activated alginate fiber. 110 g of N,N-diisopropylethylamine is added into 5500 g of chloroform solution (triphenylphosphine: 0.235%, and iodine: 0.228%) with stirring at 70 r / min, and the stirring time is counted by a timer. After stirring for 1-2 minutes, the primary activated alginate fiber is placed into the chloroform solution. The chloroform solution is stirred for 3 to 5 minutes, and then the primary activated alg...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Temperatureaaaaaaaaaa
Temperatureaaaaaaaaaa
Temperatureaaaaaaaaaa
Login to View More

Abstract

The present disclosure provides an antimicrobial alginate fiber, a method for manufacturing an antimicrobial alginate fiber dressing thereof, and an application thereof. When the cationic polymer polyhexamethylene guanide salt is mixed with the anionic polymer alginate, the antimicrobial activity of the guanide salt is quickly passivated. The present disclosure achieves a lower content of polyhexamethylene guanide salt in an alginate dressing with good long-term antimicrobial activities. The polyhexamethylene guanide salt has a low dissolution rate, and significantly reduces a potential risk of carcinogenicity, mutagenicity and reproductive toxicity.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]The present application is a continuation-in-part of International (PCT) Patent Application No. PCT / CN2017 / 094221, filed on Jul. 25, 2017, the entire contents of which are hereby incorporated by reference.TECHNICAL FIELD[0002]The described embodiments relate to a medical field of wound care or wound healing; and more particularly, to a manufacturing method and application of an antimicrobial alginate fiber and dressing materials thereof.BACKGROUND[0003]The alginate dressing may form a soft gel, after absorbing fluid exudating from a wound, providing an ideal moist environment for promoting wound healing and relieving wound pain. The alginate dressing has advantages of safety, non-toxicity, high hygroscopicity, hemostasis, gelation, and promoting wound healing, so that it is widely used in the field of wound care. However, the alginate dressing lacks antimicrobial properties.[0004]Because polyhexamethylene biguanide salt is highly cationic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): D01F9/04A61L15/28D01F11/00D06M15/564A61F13/00
CPCD01F11/00A61F2013/00229A61L15/42A61L15/28D06M15/564D01F9/04A61F13/00063A61L15/46A61L2300/404A61L2300/206D06M15/61D06M16/00D06M2400/01C08L5/04
Inventor MENG, YONGGANGMO, JINWEN
Owner HUIZHOU HUAYANG MEDICAL EQUIP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products